27.07.2013 Views

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

2644 COVALENT BINDING OF 14 C 2-METHOXY-4-<br />

NITROANILINE IN MALE SPRAGUE-DAWLEY RATS.<br />

R. Snyder 1 , S. Waidyanatha 2 , I. Surh 2 , T. Banks 1 , P. Patel 1 , S. Black 1 and T.<br />

Fennell 1 . 1 RTI International, Research Triangle Park, NC and 2 National <strong>Toxicology</strong><br />

Program, National Institute <strong>of</strong> Environmental Health Sciences, Research Triangle<br />

Park, NC.<br />

2-Methoxy-4-nitroaniline (MNA) is used in dyeing textiles, as a dye in the printing<br />

industry, and as an intermediate in the synthesis <strong>of</strong> azo dyes that have applications<br />

in tattoo inks, emulsion paints, and toy enamels. MNA has structural similarity to<br />

the known carcinogens, 2-methoxy-5-nitroaniline (5-nitro-o-anisidine), o-anisidine<br />

and 2,4-diaminoanisole. <strong>The</strong> objective <strong>of</strong> this study was to evaluate the ability<br />

<strong>of</strong> MNA-derived metabolites to bind covalently to tissue macromolecules in<br />

rats. [Ring- 14 C] MNA was administered at 150 mg/kg b. wt. to male Sprague<br />

Dawley rats (approximately 220 μCi/rat) by gavage. After 24 h, animals were euthanized<br />

and blood and selected tissues were collected and analyzed for total radioactivity<br />

in tissues, radioactivity bound to tissues and to DNA. In tissues, the total radioactivity<br />

was highest in liver (0.31 ± 0.04 % <strong>of</strong> the dose) and kidney (0.053 ±<br />

0.021 %). However, the concentration <strong>of</strong> radioactivity was highest in kidney and<br />

cecum (91 ± 4 and 22 ± 1 μg equiv/g tissue, respectively). Concentrations were<br />

similar in ileum, jejunum, and large intestine (approximately 16 μg equiv/g).<br />

Radioactivity bound determined by exhaustive extraction was highest in liver (43%<br />

<strong>of</strong> the total in tissue) followed by kidney (13 % <strong>of</strong> the total in tissue), cecum (12 %)<br />

stomach (9 %), and large intestine (9 %). Binding was low in ileum, jejunum, and<br />

duodenum (1-2% bound). In red blood cells, 27% <strong>of</strong> the activity was bound compared<br />

with 3% in plasma. Radioactivity associated with DNA (pmol equiv/mg<br />

DNA) was highest in the cecum (160 ± 27 pmol/mg) followed by large intestine<br />

(13 ± 2 pmol/mg), and was not significantly above background in other tissues.<br />

<strong>The</strong>se studies suggest that MNA is metabolized to reactive species that are capable<br />

<strong>of</strong> binding to macromolecules including DNA. <strong>The</strong> nature <strong>of</strong> the metabolites <strong>of</strong><br />

MNA is under investigation in companion studies.<br />

2645 DIFFERENTIAL MODULATION OF CANCER-RELATED<br />

MOLECULAR NETWORKS IN HUMAN AND RAT<br />

URINARY BLADDER CELLS EXPOSED TO TRIVALENT<br />

ARSENICALS.<br />

K. Bailey 1 , K. Wallace 2 , S. Thai 2 , D. C. Wolf 2 , S. W. Edwards 2 and R. C. Fry 1 .<br />

1 Environmental Sciences and Engineering, University <strong>of</strong> North Carolina at Chapel<br />

Hill, Chapel Hill, NC and 2 U.S. EPA, Research Triangle Park, NC.<br />

Arsenic (As) is classified as a known human carcinogen with primary targets <strong>of</strong> urinary<br />

bladder (UB), skin and lung. <strong>The</strong> most prevalent source <strong>of</strong> As exposure in humans<br />

is drinking water contaminated with inorganic As (iAs). <strong>The</strong> mode <strong>of</strong> action<br />

(MOA) <strong>of</strong> As carcinogenesis in target cells is largely undefined, including which arsenical(s)<br />

elicit a carcinogenic response. Two urinary metabolites <strong>of</strong> iAs,<br />

monomethylarsonous acid and dimethylarsinous acid (MMAIII and DMAIII, respectively),<br />

are attractive candidates as UB carcinogens. We used a transcriptomics<br />

approach to examine the altered molecular pathways and networks in human and<br />

rat UB cells after exposure to individual arsenicals to investigate the MOA <strong>of</strong> Asdriven<br />

UB carcinogenesis. UROtsa (human) and MYP3 (rat) cells were exposed to<br />

relatively non-cytotoxic (>75% cell viability), environmentally-relevant concentrations<br />

(1 μM) <strong>of</strong> iAsIII, MMAIII, and DMAIII for 24 h. Differentially expressed<br />

genes were determined for each treatment group relative to controls and analyzed<br />

for statistically significant biological functions, molecular networks and canonical<br />

pathways. Each treatment group elicited a distinct transcriptional pr<strong>of</strong>ile with few<br />

shared genes in top networks or canonical pathways, although lipid metabolism was<br />

a function associated with all top networks. Distinct from the other groups,<br />

MMAIII exposure in UROtsa cells generated changes in several top molecular networks<br />

that are consistent with pathways suspected to play key roles in human UB<br />

carcinogenesis, suggesting that common factors may drive UB carcinogenesis in humans<br />

and that they may be distinct from those in rats. [This abstract does not necessarily<br />

reflect EPA policy.]<br />

2646 THE EFFECTS OF ORAL TREATMENT WITH<br />

TRANSFLUTHRIN ON THE BLADDER EPITHELIUM<br />

OF RATS AND MICE AND ITS METABOLITE,<br />

TETRAFLUOROBENZOIC ACID ON UROTHELIAL<br />

CELLS IN VITRO.<br />

S. M. Cohen 1 , L. Arnold 1 , S. Lautraite 2 , L. Sheets 2 , S. Wason 2 , B. Stahl 2 , D.<br />

Eigenberg 3 , K. L. Pennington 1 , S. Kakiuchi-Kiyota 1 and M. Yokohira 1 .<br />

1 University <strong>of</strong> Nebraska Medical Center, Omaha, NE, 2 Bayer AG, Bayer<br />

CropScience, Monheim, Germany and 3 Xenometrics, Stilwell, KS.<br />

Transfluthrin, a pyrethroid insecticide, induced urinary bladder tumors in rats but<br />

not in mice in 2-year bioassays. <strong>The</strong> mechanism was investigated via an in vivo<br />

study with transfluthrin in rats and mice and in vitro studies to examine the effects<br />

<strong>of</strong> its major metabolite tetrafluorobenzoic acid (TFBA) on rat (MYP3) and human<br />

(1T1) urothelial cell lines. For the in vivo study, rats were fed diet containing 0,<br />

2000 or 5000 ppm transfluthrin for 4 weeks, 0 or 2000 ppm for 13 weeks, or coadminstered<br />

1.25% NH4Cl with 0 or 5000 ppm transfluthrin to evaluate the effects<br />

<strong>of</strong> acidification <strong>of</strong> the urine. Mice were treated with 0 or 1000 ppm transfluthrin<br />

for 4 weeks. After 4 weeks, there was no evidence <strong>of</strong> hyperplasia or<br />

increased bromodeoxyuridine labeling index in any treatment group. After 13<br />

weeks treatment with 2000 ppm transfluthrin, cytotoxicity and necrosis <strong>of</strong> the<br />

urothelial superficial layer were detected in the rat bladder by scanning electron microscopy.<br />

<strong>The</strong> urinary concentration <strong>of</strong> TFBA in rats fed 2000 ppm transfluthrin<br />

was 2.94±0.67 mM. <strong>The</strong> LC50 <strong>of</strong> TFBA was 2.25 mM for MYP3 cells and 2.43<br />

mM for 1T1 cells. <strong>The</strong>se studies support cytotoxicity and regenerative proliferation<br />

as the mechanism for induction <strong>of</strong> bladder tumors with high oral doses <strong>of</strong> transfluthrin<br />

due to metabolism <strong>of</strong> transfluthrin to the weakly cytotoxic TFBA that is<br />

excreted at high concentrations in the urine <strong>of</strong> rats administered high doses <strong>of</strong><br />

transfluthrin (≥2000 ppm) for an extended period.<br />

2647 NEUROBEHAVIORAL ALTERATIONS IN CARG-BOX<br />

BINDING FACTOR-A KNOCK-OUT MICE.<br />

J. T. Barrett 1, 2 , J. R. Richardson 2 , X. Zhang 3 , M. Fang 2 , K. R. Reuhl 2, 4 and H.<br />

Zarbl 2 . 1 GSBS, UMDNJ, Piscataway, NJ, 2 EOHSI, RWJMS, UMDNJ, Piscataway,<br />

NJ, 3 University <strong>of</strong> Washington, Seattle, WA and 4 Rutgers, Piscataway, NJ.<br />

CArG-box binding factor A (CBF-A) is a member <strong>of</strong> the heterogeneous nuclear ribonucleoproteins<br />

(hnRNPs) family <strong>of</strong> RNA-binding proteins that are involved in a<br />

variety <strong>of</strong> cellular functions. We previously showed that deregulation <strong>of</strong> CBF-<br />

A/hnRNP A/B is involved in transcriptional regulation <strong>of</strong> the HA-ras promoter and<br />

contributes to mammary carcinogenesis. Recently, we have developed CBF-A<br />

knock-out mouse models to further study the functions <strong>of</strong> this hnRNP protein. In<br />

addition to its role in mammary carcinogenesis, CBF-A is also expressed in the<br />

brain and is involved in regulation <strong>of</strong> immediate early gene expression.<br />

Furthermore, a single nucleotide polymorphism (SNP) in the arginine vasopressin<br />

gene promoter that reduced CBF-A binding was associated with alterations in anxiety<br />

behavior. To directly determine the role <strong>of</strong> CBF-A in neurobehavior, we assessed<br />

open-field locomotor function and anxiety behavior in an elevated plus maze<br />

for wild type, heterozygous, and CBF-A null mice. For locomotor activity, mice<br />

were allowed to habituate to the open-field for 30 min and ambulatory distance<br />

and vertical counts were calculated over the next 30 min. For the elevated plus<br />

maze, mice were allowed to freely explore the maze for 5 min, and percent time<br />

spent in the open arms was determined. In both tasks, there were no significant differences<br />

between wild-type and mice heterozygous for CBF-A. However, ambulatory<br />

distance traveled was increased by 89% in CBF-A null mice compared to wildtype.<br />

CBF-A null mice also demonstrated a 230% increase in vertical activity. In<br />

the elevated plus maze, CBF-A null mice spent 319% more time in the open arms<br />

<strong>of</strong> the maze compared to wild-type, suggesting that loss <strong>of</strong> CBF-A results in a lowanxiety<br />

phenotype. Taken in concert, these data suggest that CBF-A plays an important<br />

role in neurobehavioral function. Supported by R01ES015991 and<br />

P30ES005022<br />

2648 INFLUENCE OF BENZO(A)PYRENE (BAP)<br />

BIOTRANSFORMATION ON BAP-INDUCED<br />

CYTOTOXICITY IN HT-29 HUMAN COLON CANCER<br />

CELLS.<br />

J. N. Myers and A. Ramesh. Biochemistry & Cancer Biology, Meharry Medical<br />

College, Nashville, TN.<br />

<strong>The</strong> majority <strong>of</strong> sporadic cancer deaths are attributed to exposure and intake <strong>of</strong> environmental<br />

toxicants. Benzo(a)pyrene (BaP) is one such ubiquitous environmental<br />

toxicant. Being a combustion byproduct, high levels <strong>of</strong> BaP have been detected in<br />

SOT 2011 ANNUAL MEETING 567

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!